Your browser doesn't support javascript.
loading
Optimal pre-emptive cytomegalovirus therapy threshold in a patient population with high prevalence of seropositive status.
Damlaj, Moussab; Khalid, Farhan; Alahmari, Bader; Alaskar, Ahmed; Ghazi, Samer; Johani, Sameera; AlSaedy, Abdulrahman; Bosaeed, Mohammad; Alhejazi, Ayman; Al-Zahrani, Mohsen.
Afiliação
  • Damlaj M; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA, Saudi Arabi
  • Khalid F; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Alahmari B; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Alaskar A; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA, Saudi Arabi
  • Ghazi S; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Johani S; Department of Microbiology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • AlSaedy A; King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA, Saudi Arabia; Division of Infectious Diseases, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Bosaeed M; Division of Infectious Diseases, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia.
  • Alhejazi A; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA, Saudi Arabi
  • Al-Zahrani M; Division of Stem Cell Transplantation and Cellular Therapy, Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, KSA, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Riyadh, KSA, Saudi Arabi
Curr Res Transl Med ; 68(3): 131-137, 2020 08.
Article em En | MEDLINE | ID: mdl-32620466

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Quimioprevenção / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Quimioprevenção / Condicionamento Pré-Transplante Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article